Pancreatic Cancer Research

ResearcherThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteActive in the last 2 years

Andrew J. Gunderson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-6316-4067; OpenAlex author ID A5073917451; NIH RePORTER profile ID 11640730. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 1)
Trials
0
Grants
1
Labs led
1
Collaborators
24
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 3 papers, 1 grant

Papers 7

  1. Lack of tumor-derived LCN2 sensitizes pancreatic cancer cells to ferroptosis induction. Co-author DOI 10.1016/j.canlet.2026.218823↗
  2. Myofibroblast programming blocks differentiation of TLS-organizing fibroblastic reticular cells in pancreatic cancer. Last author DOI 10.1016/j.ccell.2026.03.004↗
  3. A Novel Mouse Model to Identify Antigen-Specific Immune Responses in Pancreatic Cancer Cachexia. Co-author DOI 10.3390/cancers18040587↗
  4. Neoadjuvant Immunotherapy for Localized Pancreatic Cancer: Challenges and Early Results. First author DOI 10.3390/cancers15153967↗
  5. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer. Co-author DOI 10.1080/2162402x.2021.1900635↗
  6. Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0238380↗
  7. Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma. Co-author DOI 10.1371/journal.pone.0211117↗

Grants 1

  1. ROLES AND MECHANISMS OF TERTIARY LYMPHOID STRUCTURES IN ANTI-TUMOR IMMUNITY R01CA286017↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael James Gough · 4 shared papers, 2019–2026 · strength 0.54
  2. Kristina Hoot Young · 4 shared papers, 2019–2026 · strength 0.54
  3. Marka R. Crittenden · 3 shared papers, 2019–2021 · strength 0.28
  4. Robert Connor Chick · 1 shared paper, 2023 · strength 0.26
  5. Jordan M. Cloyd · 1 shared paper, 2023 · strength 0.26
  6. Shafia Rahman · 1 shared paper, 2023 · strength 0.26
  7. Elijah Kirschstein · 1 shared paper, 2026 · strength 0.26
  8. Hsiang‐Yin Hsueh · 1 shared paper, 2026 · strength 0.24
  9. Valentina Pita-Grisanti · 1 shared paper, 2026 · strength 0.24
  10. Kristyn Gumpper · 1 shared paper, 2026 · strength 0.24
  11. Ericka Vélez-Bonet · 1 shared paper, 2026 · strength 0.24
  12. Zobeida Cruz‐Monserrate · 1 shared paper, 2026 · strength 0.24
  13. Florencia M. McAllister · 1 shared paper, 2026 · strength 0.24
  14. Mitch A. Phelps · 1 shared paper, 2026 · strength 0.22
  15. Justin W. Thomas · 1 shared paper, 2026 · strength 0.22
  16. Debasmita Mukherjee · 1 shared paper, 2026 · strength 0.22
  17. Ayushi Das · 1 shared paper, 2026 · strength 0.22
  18. Thomas A. Mace · 1 shared paper, 2026 · strength 0.22
  19. Terry R. Medler · 2 shared papers, 2020–2021 · strength 0.19
  20. Paul Hansen · 2 shared papers, 2020–2021 · strength 0.19
  21. Ephraim Shin-Tian Tang · 2 shared papers, 2020–2021 · strength 0.19
  22. Brady M. Bernard · 2 shared papers, 2020–2021 · strength 0.19
  23. Eric Tran · 1 shared paper, 2021 · strength 0.10
  24. Zeljka Jutric · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.